Monitoring suPAR levels in post-kidney transplant focal segmental glomerulosclerosis

Fri Jan 04 2019

New abstract published in BMC Nephrology;

“Monitoring suPAR levels in post-kidney transplant focal segmental glomerulosclerosis treated with therapeutic plasma exchange and rituximab” by Alachkar N. et al.

Conclusion:

“In this study of post transplant FSGS patients managed with TPE and rituximab, the reduction of suPAR after treatment contributed significantly to the reduction in proteinuria as well as to the response to therapy. These findings support monitoring of suPAR in TPE and rituximab managed recurrent and de novo FSGS”.

pdfLink to abstract here

+700

published suPAR studies in leading medical journals

The suPARnostic® brand consists of 3 products:

Photo of The suPARnostic® Quick Triage kit

Quick Triage

A Point of Care Solution

Photo of suPARnostic® TurbiLatex

TurbiLatex

For Automated Systems

Photo of suPARnostic® ELISA

ELISA Assay

Clinical and Research

Would you like to know more?

If you have any questions regarding our products or business, write to us here

Thank you!

You'll hear from us shortly.

An error occured!

Please try again, or contact us by e-mail if the problem persist.

Sign up for our newsletter

By signing up for our newsletter you will receive the latest news about our products.

Thank you!

You'll hear from us shortly.

An error occured!

Please try again, or contact us by e-mail if the problem persist.

New Webinar

Webinar

Catch COVID-19

-Improve your triage

Sign up to view webinar recording

View recording

suPARnostic® by ViroGates